KARINA MASHBURN: Open Payments
NPI 1689388043 · SALISBURY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,216 in 107 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $194 · 2025 $2,216
Food & beverage: $2,216
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $666 |
| Novo Nordisk Inc | 18 | $304 |
| AstraZeneca Pharmaceuticals LP | 8 | $270 |
| GlaxoSmithKline, LLC. | 12 | $167 |
| PFIZER INC. | 8 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $124 |
| Paratek Pharmaceuticals, Inc. | 2 | $114 |
| Exact Sciences Corporation | 5 | $93 |
| Phathom Pharmaceuticals, Inc. | 5 | $75 |
| Axsome Therapeutics, Inc. | 3 | $74 |
Products named: UBRELVY, AIRSUPRA, Wegovy, TRELEGY ELLIPTA, VRAYLAR, NURTEC ODT, Kerendia, QULIPTA.
Industry payments across NC — which companies pay providers there.
